2013
Search results
May 16, 2024 · Closing Bell. Watch CNBC’s full interview with 23andme CEO Anne Wojcicki. Anne Wojcicki, 23andme CEO, joins ‘Closing Bell’ to discuss its second quarter report and what’s driving growth for...
May 24, 2024 · 23andMe Holding Co. (ME) disclosed a strategic review to enhance shareholder value and a potential acquisition offer from CEO Anne Wojcicki during its Fiscal Year 2024 Fourth Quarter and...
May 24, 2024 · Anne Wojcicki is the CEO and co-founder of 23andMe. She co-founded 23andMe in 2006 after a decade spent in healthcare, focusing primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information, and to create a way to generate more personalized information so that commercial and academic ...
6 days ago · Anne Wojcicki is an American businesswoman and the co-founder and CEO of 23andMe, which is a personal genomics company. She has a degree in biology from Yale University and has worked as a healthcare investment analyst at Passport Capital and as a healthcare consultant at Montgomery Securities and Rosenbach Company.
3 days ago · Statistics. Forecast. Profile. Chart. Company Description. 23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics.
May 23, 2024 · Backing up that sentiment, 23andMe CEO Anne Wojcicki stated: “We all have some disease or health issue that we care about. By working with GSK, we believe 23andMe’s scientists and researchers can more quickly make the kind of breakthroughs that make a difference.” But do we ALL have some disease or health issue we care about? I’m not so sure.
May 23, 2024 · On April 18, 2024 the Company announced it has been made aware that Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, is considering making a...
